Trial Profile
A Study to Evaluate the Efficacy and Safety of Pirfenidone for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2016
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions; Therapeutic Use
- 07 Jul 2016 New trial record
- 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society